KDEVF
Price:
$0.2576
Market Cap:
$75.73M
Karolinska Development AB (publ) operates as a venture capital firm, primarily focused on providing funding to nascent companies across seed, early, and growth stages. Its investment strategy targets a wide array of life science domains, including pharmaceutical and genetic research and development, medical advancements, healthcare technology, innovative drug delivery systems, biotechnology, and specialized tools and service providers for the life science industry. The company strategically prioritizes investment opportunities within the Nordic region, specifically highlighting Sweden, Iceland, Norway, Finland, and Denmark. While the firm prefers to assume the role of a lead investor in its ...[Read more]
Industry
Biotechnology
IPO Date
2019-04-05
Stock Exchange
OTC
Ticker
KDEVF
According to Karolinska Development AB (publ)’s latest financial reports and current stock price. The company's current ROE is -19.50%. This represents a change of 302.02% compared to the average of -4.85% of the last 4 quarters.
The mean historical ROE of Karolinska Development AB (publ) over the last ten years is -62.66%. The current -19.50% ROE has changed -68.88% with respect to the historical average. Over the past ten years (40 quarters), KDEVF's ROE was at its highest in in the September 2017 quarter at 82.55%. The ROE was at its lowest in in the June 2016 quarter at -107.33%.
Average
-62.66%
Median
-0.11%
Minimum
-727.26%
Maximum
67.23%
Discovering the peaks and valleys of Karolinska Development AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.74%
Maximum Annual ROE = 67.23%
Minimum Annual Increase = -251.39%
Minimum Annual ROE = -727.26%
| Year | ROE | Change |
|---|---|---|
| 2025 | -18.55% | 2.74% |
| 2024 | -0.65% | -251.39% |
| 2023 | 0.43% | -103.70% |
| 2022 | -11.68% | -132.06% |
| 2021 | 36.44% | -175.65% |
| 2020 | -48.17% | -173.80% |
| 2019 | 65.27% | 533.21% |
| 2018 | 10.31% | -84.67% |
| 2017 | 67.23% | -109.24% |
| 2016 | -727.26% | 70.93% |
The current ROE of Karolinska Development AB (publ) (KDEVF) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.26%
5-year avg
1.20%
10-year avg
-62.66%
Karolinska Development AB (publ)’s ROE is greater than E-therapeutics Plc (-40.58%), greater than Biostage, Inc. (-786.49%), less than Oncopeptides AB (publ) (2.08%), greater than Herantis Pharma Oyj (-21354.84%), greater than Medivir AB (publ) (-37.65%), greater than SymBio Pharmaceuticals Limited (-424.34%), greater than Mindset Pharma Inc. (-316.17%), greater than Ecofibre Limited (-77.39%), greater than Abliva AB (publ) (-144.27%), less than Kiaro Holdings Corp. (0%),
| Company | ROE | Market cap |
|---|---|---|
| -40.58% | $75.96M | |
| -786.49% | $57.82M | |
| 2.08% | $55.98M | |
| -21354.84% | $59.47M | |
| -37.65% | $45.78M | |
| -424.34% | $26.38M | |
| -316.17% | $54.51M | |
| -77.39% | $73.67M | |
| -144.27% | $45.13M | |
| 0% | $442.00 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Karolinska Development AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Karolinska Development AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Karolinska Development AB (publ)'s ROE?
How is the ROE calculated for Karolinska Development AB (publ) (KDEVF)?
What is the highest ROE for Karolinska Development AB (publ) (KDEVF)?
What is the 3-year average ROE for Karolinska Development AB (publ) (KDEVF)?
What is the 5-year average ROE for Karolinska Development AB (publ) (KDEVF)?
How does the current ROE for Karolinska Development AB (publ) (KDEVF) compare to its historical average?